2Seventy

FDA Approves Bristol-Myers/2seventy Bio's Abecma For Earlier Use In Pretreated Blood Cancer Patients With Updated Boxed Warning On Secondary Cancer - 2seventy bio (NASDAQ:TSVT), Bristol-Myers Squibb (NYSE:BMY)

FDA Approves Bristol-Myers/2seventy Bio’s Abecma For Earlier Use In Pretreated Blood Cancer Patients With Updated Boxed Warning On Secondary Cancer – 2seventy bio (NASDAQ:TSVT), Bristol-Myers Squibb (NYSE:BMY)

Why Is 2seventy bio Stock Trading Higher On Monday? - Legend Biotech (NASDAQ:LEGN), Johnson & Johnson (NYSE:JNJ), 2seventy bio (NASDAQ:TSVT), Bristol-Myers Squibb (NYSE:BMY)

Why Is 2seventy bio Stock Trading Higher On Monday? – Legend Biotech (NASDAQ:LEGN), Johnson & Johnson (NYSE:JNJ), 2seventy bio (NASDAQ:TSVT), Bristol-Myers Squibb (NYSE:BMY)

Thinking about trading options or stock in General Motors, Meta Platforms, Archer-Daniels-Midland, Eli Lilly, or Celestica? - Archer-Daniels Midland (NYSE:ADM), Celestica (NYSE:CLS)

Thinking about buying stock in 2Seventy Bio, Verb Technology, Exscientia, MicroCloud Hologram, or Akebia Therapeutics? – Akebia Therapeutics (NASDAQ:AKBA), Exscientia (NASDAQ:EXAI)

top